Prostate cancer is the most common cancer among American men and the second leading cause of cancer deaths in men, according to the American Cancer Society. While PSA screening is widely used for the early detection of prostate cancer, it is also associated with a high rate of overdiagnosis, which can lead to unnecessary treatment and anxiety.
Researchers at Memorial Sloan-Kettering Cancer Center have found that change in PSA levels over time -- known as PSA velocity -- is a poor predictor of prostate cancer and may lead to many unnecessary biopsies.
Read more of the article 'Change in PSA level does not predict prostate cancer, study finds' on ScienceDaily
No comments:
Post a Comment
Please be courteous and add your name rather than 'Anonymous' to your comment, as it may not be published. In the 'Comment as' box above use the drop-down menu and select 'Name/URL'. In the 'Edit profile' pop-up enter your name and press continue. There will be a period of delay before your comment appears on the article until I receive the automatic notification that you have made one and can authorised its publication.
Any comment that includes vulgar language, racist remarks or anything of that nature will either be edited or not published at my discretion.